1979 - Fellow of the American Psychological Association (APA)
Martha Storandt spends much of her time researching Alzheimer's disease, Dementia, Clinical Dementia Rating, Gerontology and Cognition. The concepts of her Alzheimer's disease study are interwoven with issues in Central nervous system disease and Pediatrics. The Dementia study combines topics in areas such as Wechsler Adult Intelligence Scale, Wechsler Memory Scale and Longitudinal study.
Her work is dedicated to discovering how Clinical Dementia Rating, Confidence interval are connected with Oncology and other disciplines. Her work carried out in the field of Gerontology brings together such families of science as Stage, Psychometrics and Cognitive impairment. Her Cognition study integrates concerns from other disciplines, such as Developmental psychology and Personality.
Her scientific interests lie mostly in Alzheimer's disease, Dementia, Developmental psychology, Audiology and Psychiatry. Her Alzheimer's disease study combines topics from a wide range of disciplines, such as Central nervous system disease, Degenerative disease and Psychometrics. Her Dementia research is multidisciplinary, incorporating elements of Wechsler Memory Scale, Cognition and Gerontology.
Her research in Developmental psychology focuses on subjects like Test, which are connected to Vocabulary. Her Audiology research also works with subjects such as
Her scientific interests lie mostly in Alzheimer's disease, Dementia, Psychiatry, Pittsburgh compound B and Internal medicine. Her research integrates issues of Effects of sleep deprivation on cognitive performance, Cognitive deficit, Cognitive decline, Biomarker and Amyloid in her study of Alzheimer's disease. Martha Storandt works on Dementia which deals in particular with Clinical Dementia Rating.
Martha Storandt combines subjects such as Senile plaques and Brain size with her study of Pittsburgh compound B. Her study focuses on the intersection of Internal medicine and fields such as Oncology with connections in the field of Hazard ratio and Confidence interval. Her Cognition research includes themes of Longitudinal study and Gerontology.
Her primary scientific interests are in Alzheimer's disease, Pittsburgh compound B, Senile plaques, Cognitive decline and Dementia. Her work carried out in the field of Alzheimer's disease brings together such families of science as Cognitive disorder, Episodic memory and Degenerative disease. Her Cognitive disorder study combines topics from a wide range of disciplines, such as Cerebral atrophy, Endocrinology, Brain size and Cognitive deficit.
Her study in Episodic memory is interdisciplinary in nature, drawing from both Working memory, Verbal memory, Longitudinal study and Gerontology. Her Degenerative disease research includes elements of Autopsy, Cerebrospinal fluid and Amyloid. Many of her research projects under Dementia are closely connected to Parahippocampal gyrus with Parahippocampal gyrus, tying the diverse disciplines of science together.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mild cognitive impairment represents early-stage Alzheimer disease.
John C. Morris;Martha Storandt;J. Phillip Miller;Daniel W. McKeel.
JAMA Neurology (2001)
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Leonard Berg;Daniel W. McKeel;J. Philip Miller;Martha Storandt.
JAMA Neurology (1998)
The AD8: A brief informant interview to detect dementia
J. E. Galvin;C. M. Roe;K. K. Powlishta;M. A. Coats.
Neurology (2005)
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
John C. Morris;Catherine M. Roe;Elizabeth A. Grant;Denise Head.
JAMA Neurology (2009)
Psychometric differentiation of mild senile dementia of the Alzheimer type.
Martha Storandt;Jack Botwinick;Warren L. Danziger;Leonard Berg.
JAMA Neurology (1984)
A prospective study of cognitive function and onset of dementia in cognitively healthy elders.
Eugene H. Rubin;Martha Storandt;J. Philip Miller;Dorothy A. Kinscherf.
JAMA Neurology (1998)
A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years☆
Lawrence A Coben;Warren Danziger;Martha Storandt.
Electroencephalography and Clinical Neurophysiology (1985)
Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B: Cognitive Decline Associated With Aβ Deposition
Martha Storandt;Mark A. Mintun;Denise Head;John C. Morris.
JAMA Neurology (2009)
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.
Martha Storandt;Elizabeth A. Grant;J. Philip Miller;John C. Morris.
Neurology (2006)
Very Mild Senile Dementia of the Alzheimer Type: II. Psychometric Test Performance
Martha Storandt;Robert D. Hill.
JAMA Neurology (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Washington University in St. Louis
Washington University in St. Louis
Washington University in St. Louis
Washington University in St. Louis
Utrecht University
Washington University in St. Louis
Washington University in St. Louis
Washington University in St. Louis
Washington University in St. Louis
Washington University in St. Louis
National University of Singapore
GDI Experts
University of Münster
Polytechnique Montréal
Adam Mickiewicz University in Poznań
University of Salford
University of Sydney
Weizmann Institute of Science
Memorial University of Newfoundland
Tulane University
Princeton University
Fujita Health University
Utrecht University
Federal Reserve Bank of Atlanta
University of Colorado Boulder
University of Wisconsin–Milwaukee